Multidrug resistance protein 4 (MRP4/ABCC4) is overexpressed in clear cell renal cell carcinoma (ccRCC) and is essential to regulate cell proliferation-Reference-Cited by-同舟云学术

Multidrug resistance protein 4 (MRP4/ABCC4) is overexpressed in clear cell renal cell carcinoma (ccRCC) and is essential to regulate cell proliferation

Published:2020-10 Issue: Volume:161 Page:836-847
ISSN:0141-8130
Container-title:International Journal of Biological Macromolecules
language:en
Short-container-title:International Journal of Biological Macromolecules

Author:

Colavita Juan Pablo Melana,Todaro Juan Santiago,de Sousa Maximiliano,May María,Gómez Natalia,Yaneff Agustin,Di Siervi Nicolas,Aguirre María Victoria,Guijas Carlos,Ferrini Leandro,Davio Carlos,Rodríguez Juan Pablo

Funder

Universidad Nacional del Nordeste

Publisher

Elsevier BV

Subject

Molecular Biology,General Medicine,Biochemistry,Structural Biology

Reference60 articles.

1. Androgen receptor (AR) promotes clear cell renal cell carcinoma (ccRCC) migration and invasion via altering the circHIAT1/miR-195-5p/29a-3p/29c-3p/CDC42 signals;Wang;Cancer Lett.,2017

2. Medical treatment of renal cancer: new horizons;Greef;Br. J. Cancer,2016

3. Mechanisms of acquired resistance to tyrosine kinase inhibitors in clear - cell renal cell carcinoma (ccRCC);Bielecka;Curr Signal Transduct Ther,2014

4. NCCN guidelines insights: kidney cancer, version 2.2020;Motzer;J. Natl. Compr. Cancer Netw.,2019

5. Renal drug transporters and drug interactions;Ivanyuk;Clin. Pharmacokinet.,2017

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resistance mechanisms and potential therapeutic strategies in relapsed or refractory natural killer/T cell lymphoma;Chinese Medical Journal;2024-08-23

2. Improved therapy for clear cell renal cell carcinoma: beta-hydroxybutyrate and quercetin target hypoxia-induced angiogenesis and multidrug resistance;Molecular Biology Reports;2024-03-02

3. ABCC4 suppresses glioblastoma progression and recurrence by restraining cGMP-PKG signalling;British Journal of Cancer;2024-02-12

4. PBRM1 mutation and WDR72 expression as potential combinatorial biomarker for predicting the response to Nivolumab in patients with ccRCC: a tumor marker prognostic study;Aging;2023-11-30

5. Total and Extracellular Vesicle cAMP Contents in Urine Are Associated with Autosomal Dominant Polycystic Kidney Disease (ADPKD) Progression;Life;2023-08-28